In brief
A funded cohort-study protocol using linked 2016-2019 Medicare data to examine how electroconvulsive therapy relates to neuropsychiatric symptoms, geriatric syndromes, admissions, and mortality in older adults with dementia; apart from a preliminary mortality observation, results are not yet reported, and ECT for...
What this article is about
Quick Answer
A funded cohort-study protocol using linked 2016-2019 Medicare data to examine how electroconvulsive therapy relates to neuropsychiatric symptoms, geriatric syndromes, admissions, and mortality in older adults with dementia; apart from a preliminary mortality observation, results are not yet reported, and ECT for these symptoms remains investigational.
Student takeaways
Key Takeaways
- This is a funded cohort-study protocol; aside from one preliminary observation, it reports aims and methods rather than confirmatory results.
- The authors state that current treatments for neuropsychiatric symptoms (agitation, aggression, depression) of dementia are mixed, and that non-pharmacological behavioral interventions are recommended first-line but are resource-intensive and may be less effective in severe cases.
- The abstract describes ECT as an effective and safe treatment for several psychiatric disorders and notes preliminary evidence from case series and naturalistic studies that it may help severe neuropsychiatric symptoms in dementia, while stressing that long-term associations are largely unexplored.
- The planned study will use 2016-2019 Medicare claims (Parts A, B, D) linked to other national datasets, with three aims: characterize ECT use and its correlates, examine longitudinal associations with neuropsychiatric symptoms and geriatric syndromes, and examine differential risks of hospital or nursing home admission and all-cause mortality.
- As a preliminary finding, the authors report that in their earlier analyses ECT use in patients with both depression and dementia was associated with a lower likelihood of all-cause mortality, leading to a hypothesis (not a conclusion) that ECT may also protect against geriatric syndromes.
Student summary
Why This Research Matters
This abstract describes a funded research project, meaning a study plan rather than completed findings, that will investigate electroconvulsive therapy, or ECT, in older adults with Alzheimer's disease and related dementias, abbreviated ADRD. The authors begin by explaining that ADRD are among the most common and disabling neurodegenerative diseases of aging. People with dementia often develop neuropsychiatric symptoms, sometimes called NPS, which include agitation, aggression, and depression. Current treatments for these symptoms are described as mixed, meaning they do not always work well. Non-pharmacological behavioral interventions, such as structured activities and environmental changes, are recommended as the first-line approach, but they require substantial time and resources and may be less effective for patients who are severely agitated, aggressive, or depressed. Against this backdrop, the researchers turn to ECT. ECT is a medical treatment in which a brief, controlled electrical stimulation is used to produce a therapeutic seizure under anesthesia. The abstract states that ECT is an effective and safe treatment for a range of psychiatric disorders, including treatment-resistant depression, schizoaffective disorder, and bipolar disorder. It also notes that case series and naturalistic studies provide preliminary evidence that ECT may help treat severe agitation, aggression, depression, or other neuropsychiatric symptoms in people with dementia. However, the authors emphasize that the long-term picture is largely unexplored: we do not yet know much about how ECT relates to lasting improvement in these symptoms, to geriatric syndromes such as functional decline and frailty, or to rates of hospital and nursing home admission and death. To address these gaps, the team proposes a nationwide cohort study using Medicare claims data from 2016 to 2019, covering Parts A, B, and D, linked with several other national data sources, including a home health assessment dataset, a Medicare beneficiary survey, and a national death index. The study has three specific aims. The first is to examine how often ECT is used and which social, demographic, and clinical factors are associated with its use. The second is to investigate the long-term associations of ECT with neuropsychiatric symptoms and geriatric syndromes. The third is to examine whether ECT use is associated with different risks of hospital or nursing home admission and death among older adults with dementia. The researchers plan advanced statistical methods, such as generalized linear mixed modeling and competing-risk regression, along with techniques called propensity-score matching and instrumental variables, which are designed to reduce the influence of confounding factors, that is, other differences between people who do and do not receive ECT. They will also conduct both intent-to-treat and as-treated analyses. Importantly, the authors share a preliminary finding from their own earlier analyses: ECT use in people with both depression and dementia was associated with a lower likelihood of death from any cause. Based on this, they hypothesize that ECT may also protect against geriatric syndromes. This is a hypothesis to be tested, not a proven conclusion. For nursing students, several points matter. First, this is a study protocol, so aside from the preliminary observation noted above, it does not provide definitive results; it lays out questions and methods. Second, it illustrates how large administrative databases can be used to study real-world treatment patterns and outcomes. Third, it shows the challenge of confounding in observational research and why methods like propensity-score matching exist. Clinical safety deserves emphasis. ECT is a serious medical procedure performed under anesthesia by specialists, and its use for neuropsychiatric symptoms of dementia is still being studied and is not a routine first-line treatment. Decisions about ECT are complex and must involve careful assessment, informed consent, and often substitute decision-makers when a person cannot consent themselves, along with attention to the person's dignity and values. Behavioral, non-drug strategies remain the recommended first step for these symptoms. Nurses caring for older adults with dementia can support safe, person-centered care by monitoring symptoms, protecting against agitation triggers, and ensuring that any treatment decision is well informed. Overall, this abstract is a carefully designed plan to build better evidence about the long-term effects of ECT in a vulnerable population.
Source abstract
Study Overview
Project Abstract Alzheimer’s disease and related dementias (ADRD) are the most prevalent, debilitating neuro-degenerative diseases of aging, and current treatments for neuropsychiatric symptoms (NPS) (e.g., agitation, aggression, and depression) of ADRD are mixed. While non-pharmacological behavioral interventions are recommended as first-line treatments for these NPS of ADRD, they require substantial time and resources, and may be less effective for severely agitated, aggressive, or depressed older patients with ADRD. Electroconvulsive therapy (ECT) is an effective and safe treatment for a range of psychiatric disorders, including treatment-resistant depression, schizoaffective disorder, and bipolar disorder. Case series and naturalistic studies support preliminary evidence for the efficacy of ECT to treat severe agitation, aggression, depression, or other NPS in ADRD. To date, associations of ECT with long-term improvement in NPS and geriatric syndromes (e.g., functional declines and frailty), as well as with hospital and nursing home admission rates and all-cause mortality rates are largely unexplored. The proposed nationwide cohort study explicitly addresses these knowledge gaps. Using the Centers for Medicare and Medicaid Services’ 2016-2019 Medicare claims data (Parts A, B, and D) linked with multiple data sources (e.g., Home Health Outcome and Assessment Information Set, Medicare Current Beneficiary Survey, and National Death Index), this proposed study features the following specific aims: 1) to examine incidence and prevalence rates of ECT use and socio-demographic and clinical factors associated with ECT use; 2) to investigate longitudinal associations of ECT with NPS and geriatric syndromes; and 3) to examine differential risks of hospital or nursing home admission rates and all-cause mortality rates by ECT use in older adults with ADRD. Longitudinal data analyses, such as generalized linear mixed modeling and competing-risk regression methods, will be used for Aims 2 and 3. In this nationwide cohort study, we will employ propensity-score matching and instrumental variable techniques to adjust for both observed and unobserved confounders. Intent-to-treat and as-treated analyses will also be conducted. Earlier studies support that ECT is associated with improvement in NPS of ADRD and our analyses show that ECT use with presence of both depression and ADRD was associated with a lower likelihood of all-cause mortality rates; we thus hypothesize that ECT may also be protective against geriatric syndromes. This is the first nationwide, longitudinal cohort study investigating the long-term effectiveness and safety of ECT in adults with ADRD. The proposed study is innovative since it will provide a better understanding of ECT use and its association with NPS, geriatric syndromes, and other health outcomes. Findings from this study will inform clinical guidance on ECT use in older adults with ADRD.
Evidence appraisal
Main Findings
- This is a funded cohort-study protocol; aside from one preliminary observation, it reports aims and methods rather than confirmatory results.
- The authors state that current treatments for neuropsychiatric symptoms (agitation, aggression, depression) of dementia are mixed, and that non-pharmacological behavioral interventions are recommended first-line but are resource-intensive and may be less effective in severe cases.
- The abstract describes ECT as an effective and safe treatment for several psychiatric disorders and notes preliminary evidence from case series and naturalistic studies that it may help severe neuropsychiatric symptoms in dementia, while stressing that long-term associations are largely unexplored.
- The planned study will use 2016-2019 Medicare claims (Parts A, B, D) linked to other national datasets, with three aims: characterize ECT use and its correlates, examine longitudinal associations with neuropsychiatric symptoms and geriatric syndromes, and examine differential risks of hospital or nursing home admission and all-cause mortality.
- As a preliminary finding, the authors report that in their earlier analyses ECT use in patients with both depression and dementia was associated with a lower likelihood of all-cause mortality, leading to a hypothesis (not a conclusion) that ECT may also protect against geriatric syndromes.
Practice transfer
Clinical Relevance
- Nurses should understand that non-pharmacological, behavioral strategies remain the recommended first-line approach for neuropsychiatric symptoms of dementia, and that ECT for these symptoms is investigational rather than routine.
- Because ECT is a specialist procedure performed under anesthesia, any consideration of it requires careful assessment, informed consent, and often substitute decision-makers, with attention to the person's dignity and values.
- Nurses can help reduce agitation and aggression by identifying and minimizing triggers, supporting familiar routines, and monitoring for treatable causes such as pain, infection, or delirium.
- Findings from observational claims-based research show associations, not proof of cause and effect, so nurses should interpret any results cautiously and avoid assuming ECT causes better outcomes.
- Given the vulnerability of older adults with dementia, nurses play a key role in advocating for person-centered, ethically sound decision-making and clear communication with families about any proposed treatment.
Faculty notes
Educational Relevance
This funded cohort-study abstract is essentially a protocol with one preliminary observation, useful for teaching observational-study appraisal and the ethics of a sensitive intervention. Use it to distinguish a plan from evidence: aside from the authors' prior analysis suggesting lower all-cause mortality when ECT is used in patients with both depression and ADRD, no confirmatory results are presented, and the protective effect on geriatric syndromes is stated as a hypothesis. The design offers strong teaching material on secondary analysis of linked administrative data (Medicare Parts A, B, D linked to Home Health OASIS, the Medicare Current Beneficiary Survey, and the National Death Index), and on confounding control, propensity-score matching, instrumental variables, generalized linear mixed models, competing-risk regression, and intent-to-treat versus as-treated analyses. It anchors discussion of neuropsychiatric symptoms in dementia, first-line non-pharmacological management, and when escalation is considered. Emphasize the clinical-safety and ethics dimension: ECT is a specialist procedure under anesthesia, its use for dementia-related NPS is investigational, and consent and surrogate decision-making are central. Ask students to critique confounding by indication, survivorship, and the limits of causal inference from claims data.
Critical appraisal
Limitations
- The abstract is largely a study proposal, so apart from one preliminary observation it presents no confirmatory results; the hypothesized protective effect on geriatric syndromes is untested.
- The planned analysis uses administrative claims data, which can show associations but cannot prove causation and may be affected by confounding by indication and other biases.
- People who receive ECT may differ systematically from those who do not, so even with propensity-score matching and instrumental variables, residual confounding is possible.
Classroom use
Discussion Questions
- What are neuropsychiatric symptoms of dementia, and why can they be difficult to treat?
- Why are non-pharmacological behavioral interventions recommended as first-line for these symptoms?
- What is ECT, and for which conditions does the abstract say it is effective and safe?
- Why does the abstract describe the long-term effects of ECT in dementia as largely unexplored?
- What are the strengths and weaknesses of using Medicare claims data to study treatment outcomes?
- What is confounding, and how do propensity-score matching and instrumental variables try to address it?
- Why is it important to distinguish association from causation when reading observational research?
- What ethical considerations arise when considering ECT for a person with dementia who may not be able to consent?
- How should a nurse respond if a family asks whether ECT will help their loved one's agitation?
- Why is the authors' preliminary mortality finding described as a hypothesis rather than a conclusion?
Search-ready answers
Frequently asked questions
Does this study prove ECT helps people with dementia?
No. It is mainly a study plan (protocol). Apart from one preliminary observation about lower mortality, it reports no confirmatory results, and its idea that ECT protects against geriatric syndromes is a hypothesis to be tested.
What is ECT?
Electroconvulsive therapy is a medical procedure in which a brief, controlled electrical stimulation induces a therapeutic seizure under anesthesia. The abstract describes it as effective and safe for several psychiatric disorders.
Is ECT a standard treatment for agitation in dementia?
No. Non-pharmacological behavioral strategies are recommended first-line. Using ECT for neuropsychiatric symptoms of dementia is still being studied and is not routine care.
What are neuropsychiatric symptoms of dementia?
They include agitation, aggression, and depression. Current treatments are described as mixed, which is part of why researchers are exploring other options.
Why use Medicare claims data?
Large administrative datasets let researchers study real-world patterns of treatment and outcomes across many people, though they can show associations rather than prove cause and effect.
What is confounding, and how is it handled?
Confounding occurs when other differences between groups distort the apparent effect of a treatment. The study plans propensity-score matching and instrumental variables to reduce it, but these cannot fully prove causation.
What was the authors' preliminary finding?
In earlier analyses, ECT use in patients who had both depression and dementia was associated with a lower likelihood of death from any cause. This led to their hypothesis, not a firm conclusion.
What ethical issues surround ECT in dementia?
ECT is a specialist procedure under anesthesia. Decisions require careful assessment, informed consent, and often substitute decision-makers when the person cannot consent, with respect for their dignity and values.
How can nurses help patients with dementia who are agitated?
Nurses can identify and reduce triggers, support familiar routines, and check for treatable causes such as pain, infection, or delirium, while ensuring any treatment decision is well informed.
Where can families get guidance about treatment decisions?
This summary is educational only. Families should discuss options, risks, and benefits with the treating specialist team and seek support from their healthcare providers.